Vivante Health provides virtual gastrointestinal care through its GIThrive platform, pairing data-driven technology with a coordinated team of physicians, registered dietitians and health coaches. The platform offers food and symptom logging, online educational resources, 24/7 access to dietitians, health coaches and nurses, and a nationwide network of internists and gastroenterologists for diagnosis, lab orders and prescriptions. Recent GIThrive enhancements add AI-driven personalized care plans that dynamically adjust to symptoms and other variables, helping bridge virtual and real-world care. The company plans to use the Series B proceeds to fund technology upgrades designed to predict the onset and progression of GI conditions and to expand its commercial and client support teams. Vivante will also invest in onboarding support for new employers, health plans and channel partners. The company is led by CEO Bill Snyder and is headquartered in Chicago, IL. Vivante Health offers an all-in-one gut health program, GIThrive, that combines technology, advanced science, and on-demand human support to improve digestive health and lower cost of care. Led by CEO Bill Snyder, the company delivers a digital solution for digestive health and disease. Vivante has partnerships with employer healthcare platforms such as Virgin Pulse and Accolade and serves clients including US Foods, Bucknell University, and Marpai. Since the beginning of 2021 the company grew its client base by 400% through the addition of key Fortune 500 clients. The company intends to use the Series A proceeds to expand operations and broaden its business reach. Vivante Health offers GIThrive, a digital digestive-health program combining at-home microbiome testing, a breath-based food-sensitivity monitor, 24/7 access to a gastrointestinal care team and additional self-management tools. The company positions GIThrive as a chronic-disease management tool tuned to individuals with gastrointestinal discomfort and illness. CEO and founder Dr. Kimon Angelides previously helped found EosHealth (later Livongo). Vivante maintains offices in Houston, Nashville, Chicago and Athens, Greece. The company has pursued selling GIThrive to health plans and employers and says the new funds will accelerate efforts to provide relief to thousands of Americans with chronic GI symptoms. The microbiome/gut wellness space includes competitors such as DayTwo and Bold Health, and the industry has been shadowed by the downfall of former frontrunner uBiome. Vivante Health offers a gut health management program called GIThrive that combines personalized nutrition plans, daily health challenges, "Med-ucation" to encourage prescription adherence, and on-demand care for symptom flares with 24/7 Gut-Side Assistance™. The platform pairs data science with access to digestive health experts to help individuals manage conditions. Dr. Kimon Angelides is the founder and CEO. The company announced a minority investment from NFP Ventures; the amount was not disclosed. No operating metrics or additional financial details were provided in the article. The company is headquartered in Houston, Texas.

Total raised

$53M

Funding rounds

4

Latest round

Series B

Latest activity

Sep 2023